SCHEMBL60410

SCHEMBL60410

CCOC(=O)C(=O)C(C)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
HPGD P15428 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GLO1 Q04760 1/20 0.40
TSHR P16473 2/20 0.39
ALOX15 P16050 2/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
EGLN1 Q9GZT9 1/20 0.38
MAPT P10636 1/20 0.36
TRPA1 O75762 1/20 0.36
CYP2D6 P10635 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145196 0.86 ALDH1A1 (0.39) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL18179071 0.86 ALDH1A1 (0.42) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL7278815 0.85 ALDH1A1 (0.41) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL14134298 0.84 ALDH1A1 (0.44) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL2775307 0.82 SOAT1 (0.41) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL141446 0.82 ALDH1A1 (0.53) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL6049861 0.81 ALDH1A1 (0.42) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL166879 0.80 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10NPSR1GLO1
Ethane SCHEMBL9181718 0.79 ALDH1A1 (0.50) ALDH1A1HPGDLMNAHSD17B10NPSR1
SCHEMBL8800602 0.79 ALDH1A1 (0.50) ALDH1A1HPGDLMNAHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
WO-2026087561-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS SIKA TECHNOLOGY AG (CH) 2026-04-30 WO claimed
EP-4733284-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS Sika Technology AG (CH) 2026-04-29 EP claimed
WO-2025019764-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS MATTERWORKS INC (US) 2025-01-23 WO claimed
EP-4437319-A1 METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION Matterworks Inc (US) 2024-10-02 EP claimed
WO-2024197225-A1 REDOX ACTIVE ANTIFOULING COATINGS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-09-26 WO claimed
US-20230137741-A1 METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION MATTERWORKS INC 2023-05-04 US claimed
WO-2023077166-A1 METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION MATTERWORKS INC (US) 2023-05-04 WO claimed
EP-4063422-A1 1,3-DICARBONYL COMPOUNDS AS RETARDING ADDITIVES FOR UCRETE SYSTEMS Construction Research & Technology GmbH (DE) 2022-09-28 EP claimed
US-20260148950-A1 METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY MATTERWORKS INC (US) 2026-05-28 US disclosed
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP disclosed
WO-2026087561-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS SIKA TECHNOLOGY AG (CH) 2026-04-30 WO disclosed
EP-4733284-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS Sika Technology AG (CH) 2026-04-29 EP disclosed
EP-4041732-B1 ISO-CITRATE DEHYDROGENASE (IDH) INHIBITOR ZHEJIANG METON PHARMACEUTICAL CO LTD (CN) 2026-03-18 EP disclosed
US-4303789-A INHIBITORS OF DIHYDROPTERIC ACID AND BIOSYNTHESIS BURROUGHS WELLCOME CO. (US) 1981-12-01 US disclosed
US-4302587-A INTERMEDIATE FOR ENZYME INHIBITING PYRIMIDO(4,5-C)PYRIDAZINES BURROUGHS WELLCOME CO. (US) 1981-11-24 US disclosed
US-4255427-A TREATMENT OF COCCIDIOSIS IN POULTRY BURROUGHS WELLCOME CO. (US) 1981-03-10 US disclosed
US-4225710-A ENZYME INHIBITORS BURROUGHS WELLCOME CO. (US) 1980-09-30 US disclosed
EP-0000382-A1 Pyrimido (4,5-c)pyridazines, compositions containing them and processes for their preparation THE WELLCOME FOUNDATION LIMITED (GB) 1979-01-24 EP disclosed
EP-0000383-A1 Pyrimido (4,5-c) pyridazines, their use in pharmaceutical preparations, and process for their preparation THE WELLCOME FOUNDATION LIMITED (GB) 1979-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260148950-A1 METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY SRMS, PTMS, CALCB ALDH1A1 4663/4885HPGD 3117/4885LMNA 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.